14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
UHT vs NHP: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Universal Health Realty Income Trust (UHT) is the stronger overall head-to-head candidate over NHP (NHP) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). UHT carries a Unified Composite Score of 42.3/100 (HOLD) at $37.22 (38.8x Forward P/E, 38.0% operating margin), whereas NHP carries 54.6/100 (HOLD) at $14.82 (N/M Forward P/E, N/A operating margin).
Composite vs. Pillar Nuance: While NHP currently prints a higher short-term Unified Composite Score (54.6/100 HOLD vs. UHT 42.3/100 HOLD), UHT captures the overall institutional head-to-head verdict (8–2 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (38.0% vs. N/A operating margin) and revenue trajectory (+0.4% vs. N/A YoY).
Technical & Structure Timing Caution: UHT is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 40.9); meanwhile NHP trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 45.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on UHT vs NHP. Trailing 12-month operating profitability (UHT 38.0% vs NHP N/A) and valuation multiples (UHT 38.8x vs NHP N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ UHT vs NHP Key Questions & Quantitative Answers
As of Nov 20, 2026, Universal Health Realty Income Trust (UHT) is the stronger overall head-to-head candidate over NHP (NHP) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). UHT carries a Unified Composite Score of 42.3/100 (HOLD) at $37.22 (38.8x Forward P/E, 38.0% operating margin), whereas NHP carries 54.6/100 (HOLD) at $14.82 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While NHP currently prints a higher short-term Unified Composite Score (54.6/100 HOLD vs. UHT 42.3/100 HOLD), UHT captures the overall institutional head-to-head verdict (8–2 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (38.0% vs. N/A operating margin) and revenue trajectory (+0.4% vs. N/A YoY). Technical & Structure Timing Caution: UHT is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 40.9); meanwhile NHP trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 45.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
UHT leads the Growth & Scale pillar: UHT posts +0.4% YoY revenue growth and +20.7% YoY earnings growth on $101M TTM revenue (94.4% gross margin, 38.0% operating margin), compared with NHP at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, UHT generates $101M in USD-normalized revenue versus N/A for NHP. In operating R&D and SG&A reinvestment, UHT deploys 56.4% of Rev ($57M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for NHP.
UHT screens cheaper on headline valuation multiples. UHT trades at 38.8x Forward P/E, 25.6x Trailing P/E, 0.63x PEG, and 5.1x EV/Revenue (64.7% EBITDA margin), whereas NHP trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against UHT (13.5% ROE) versus NHP (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, UHT carries 23.6% implied volatility (14th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.06β · 24% Vol realized risk). By comparison, NHP carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.20β · 34% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.